← Open Payments lookup

JENNIFER VERMAAK: Open Payments

NPI 1700118882 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$434 in 17 payments from 8 companies in 2025. Trend: 2023 $756 · 2024 $16 · 2025 $434

Food & beverage: $334Education: $100
CompanyPaymentsAmount
Janssen Biotech, Inc.2$121
ABBVIE INC.4$96
UCB, Inc.3$67
Lilly USA, LLC3$50
Aimmune Therapeutics, Inc.2$35
Neurocrine BioSciences, Inc.1$25
Exact Sciences Corporation1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20

Products named: TREMFYA, Bimzelx, SKYRIZI, TALTZ, RINVOQ, INGREZZA, The Cologuard Plus Collection Kit, CAPLYTA.

Industry payments across MS — which companies pay providers there.